AI Verdict
IDXX has stronger fundamentals based on our AI analysis.
IDXX vs MRK Fundamental Comparison
| Metric | IDXX | MRK |
|---|---|---|
| Revenue | $4.3B | $65.0B |
| Net Income | $1.1B | $18.3B |
| Net Margin | 24.6% | 28.1% |
| ROE | 66.0% | 34.7% |
| ROA | 31.6% | 13.3% |
| Current Ratio | 1.23x | 1.54x |
| Debt/Equity | 0.28x | 0.89x |
| EPS | $13.08 | $7.28 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IDXX vs MRK: Frequently Asked Questions
Is IDXX or MRK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IDXX has stronger fundamentals. IDXX is rated STRONG BUY (87% confidence) while MRK is rated BUY (80% confidence). This is not investment advice.
How does IDXX compare to MRK fundamentally?
IDEXX LABORATORIES INC /DE has ROE of 66.0% vs Merck & Co., Inc.'s 34.7%. Net margins are 24.6% vs 28.1% respectively.
Which stock pays higher dividends, IDXX or MRK?
IDXX has a dividend yield of N/A or no dividend while MRK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IDXX or MRK for long term?
For long-term investing, consider that IDXX has STRONG BUY rating with 87% confidence, while MRK has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IDXX vs MRK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IDXX vs MRK, the AI consensus favors IDXX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.